Humana Statistics
Total Valuation
Humana has a market cap or net worth of $28.41 billion. The enterprise value is $37.89 billion.
Important Dates
The next confirmed earnings date is Wednesday, July 30, 2025, before market open.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | Jun 27, 2025 |
Share Statistics
Humana has 120.69 million shares outstanding. The number of shares has decreased by -2.11% in one year.
| Current Share Class | 120.69M |
| Shares Outstanding | 120.69M |
| Shares Change (YoY) | -2.11% |
| Shares Change (QoQ) | +0.32% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 96.23% |
| Float | 120.46M |
Valuation Ratios
The trailing PE ratio is 16.62 and the forward PE ratio is 15.15. Humana's PEG ratio is 1.55.
| PE Ratio | 16.62 |
| Forward PE | 15.15 |
| PS Ratio | 0.24 |
| Forward PS | 0.22 |
| PB Ratio | 1.60 |
| P/TBV Ratio | 4.24 |
| P/FCF Ratio | 11.93 |
| P/OCF Ratio | 9.89 |
| PEG Ratio | 1.55 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 9.25, with an EV/FCF ratio of 15.92.
| EV / Earnings | 22.16 |
| EV / Sales | 0.32 |
| EV / EBITDA | 9.25 |
| EV / EBIT | 9.93 |
| EV / FCF | 15.92 |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.77.
| Current Ratio | 1.91 |
| Quick Ratio | 1.47 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | 3.20 |
| Debt / FCF | 5.77 |
| Interest Coverage | 5.77 |
Financial Efficiency
Return on equity (ROE) is 10.10% and return on invested capital (ROIC) is 7.78%.
| Return on Equity (ROE) | 10.10% |
| Return on Assets (ROA) | 4.72% |
| Return on Invested Capital (ROIC) | 7.78% |
| Return on Capital Employed (ROCE) | 11.60% |
| Revenue Per Employee | $1.83M |
| Profits Per Employee | $26,035 |
| Employee Count | 65,680 |
| Asset Turnover | 2.38 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Humana has paid $568.00 million in taxes.
| Income Tax | 568.00M |
| Effective Tax Rate | 24.86% |
Stock Price Statistics
The stock price has decreased by -34.42% in the last 52 weeks. The beta is 0.44, so Humana's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | -34.42% |
| 50-Day Moving Average | 249.98 |
| 200-Day Moving Average | 271.59 |
| Relative Strength Index (RSI) | 47.40 |
| Average Volume (20 Days) | 1,738,967 |
Short Selling Information
The latest short interest is 3.94 million, so 3.27% of the outstanding shares have been sold short.
| Short Interest | 3.94M |
| Short Previous Month | 3.09M |
| Short % of Shares Out | 3.27% |
| Short % of Float | 3.27% |
| Short Ratio (days to cover) | 1.96 |
Income Statement
In the last 12 months, Humana had revenue of $120.26 billion and earned $1.71 billion in profits. Earnings per share was $14.16.
| Revenue | 120.26B |
| Gross Profit | 18.19B |
| Operating Income | 3.82B |
| Pretax Income | 2.37B |
| Net Income | 1.71B |
| EBITDA | 4.10B |
| EBIT | 3.82B |
| Earnings Per Share (EPS) | $14.16 |
Full Income StatementBalance Sheet
The company has $22.14 billion in cash and $13.73 billion in debt, giving a net cash position of -$9.48 billion or -$78.58 per share.
| Cash & Cash Equivalents | 22.14B |
| Total Debt | 13.73B |
| Net Cash | -9.48B |
| Net Cash Per Share | -$78.58 |
| Equity (Book Value) | 17.82B |
| Book Value Per Share | 147.08 |
| Working Capital | 16.38B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $2.87 billion and capital expenditures -$493.00 million, giving a free cash flow of $2.38 billion.
| Operating Cash Flow | 2.87B |
| Capital Expenditures | -493.00M |
| Free Cash Flow | 2.38B |
| FCF Per Share | $19.73 |
Full Cash Flow StatementMargins
Gross margin is 15.12%, with operating and profit margins of 3.17% and 1.42%.
| Gross Margin | 15.12% |
| Operating Margin | 3.17% |
| Pretax Margin | 1.90% |
| Profit Margin | 1.42% |
| EBITDA Margin | 3.41% |
| EBIT Margin | 3.17% |
| FCF Margin | 1.98% |
Dividends & Yields
This stock pays an annual dividend of $3.54, which amounts to a dividend yield of 1.50%.
| Dividend Per Share | $3.54 |
| Dividend Yield | 1.50% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 25.00% |
| Buyback Yield | 2.11% |
| Shareholder Yield | 3.62% |
| Earnings Yield | 6.02% |
| FCF Yield | 8.38% |
Dividend DetailsAnalyst Forecast
The average price target for Humana is $282.70, which is 20.10% higher than the current price. The consensus rating is "Hold".
| Price Target | $282.70 |
| Price Target Difference | 20.10% |
| Analyst Consensus | Hold |
| Analyst Count | 21 |
| Revenue Growth Forecast (5Y) | 8.01% |
| EPS Growth Forecast (5Y) | 31.16% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on August 1, 1991. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Aug 1, 1991 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |